Equity Capital Markets

All filings · since 4 November 2002

Filings

Every share-offering filing on EDGAR since the day foreign issuers also had to file electronically. One row per filer: a filing made by a parent and its subsidiaries appears once for each of them, as in SEC's own index.

Source: SEC EDGAR · as of 2026-10-27 06:30 UTC · latest filing day 2026-10-26

Page 1 · newest first · 50 per pageDownload as CSV (up to 5,000 rows)
FiledCompanyFilingAccession
2025-12-12
Immunovant, Inc.
ShelfEffectiveCIK 1764013
 424B5Shelf takedown0001193125-25-316765
2023-11-09
Immunovant, Inc.
ShelfEffectiveCIK 1764013
 S-3ASRShelf registered0001193125-23-274103
2023-09-29
Immunovant, Inc.
ShelfEffectiveCIK 1764013
 424B5Shelf takedown0001193125-23-247518
2023-09-26
Immunovant, Inc.
ShelfEffectiveCIK 1764013
 424B5Shelf takedown0001193125-23-242623
2022-10-05
Immunovant, Inc.
ShelfEffectiveCIK 1764013
 424B5Shelf takedown0001193125-22-258261
2021-01-15
Immunovant, Inc.
ShelfEffectiveCIK 1764013
 424B5Shelf takedown0001628280-21-000468
2021-01-14
Immunovant, Inc.
ShelfEffectiveCIK 1764013
 EFFECTDeclared effective9999999995-21-000163
2021-01-04
Immunovant, Inc.
ShelfEffectiveCIK 1764013
 S-3Shelf registered0001628280-21-000004
2020-09-03
Immunovant, Inc.
Registered companyFinal prospectusCIK 1764013
 424B4Final prospectus0001193125-20-238296
2020-09-01
Immunovant, Inc.
Registered companyFinal prospectusCIK 1764013
 EFFECTDeclared effective9999999995-20-002339
2020-08-31
Immunovant, Inc.
Registered companyFinal prospectusCIK 1764013
 S-1Registration filed0001193125-20-235301
2020-08-19
Immunovant, Inc.
CIK 1764013
 DRSDraft made public0000950123-20-009237
2020-04-14
Immunovant, Inc.
Registered companyFinal prospectusCIK 1764013
 EFFECTDeclared effective9999999995-20-000752
2020-04-14
Immunovant, Inc.
Registered companyFinal prospectusCIK 1764013
 424B4Final prospectus0001193125-20-107237
2020-04-10
Immunovant, Inc.
Registered companyFinal prospectusCIK 1764013
 S-1Registration filed0001193125-20-103101
2020-04-09
Immunovant, Inc.
Registered companyEffectiveCIK 1764013
 EFFECTDeclared effective9999999995-20-000718
2020-04-08
Immunovant, Inc.
Registered companyEffectiveCIK 1764013
 S-1/AAmendment0001193125-20-100937
2020-04-03
Immunovant, Inc.
Registered companyEffectiveCIK 1764013
 S-1/AAmendment0001193125-20-096678
2020-04-01
Immunovant, Inc.
CIK 1764013
 DRSDraft made public0000950123-20-003093
2020-02-28
Immunovant, Inc.
Registered companyEffectiveCIK 1764013
 S-1/AAmendment0001193125-20-056986
2020-01-17
Immunovant, Inc.
Registered companyEffectiveCIK 1764013
 S-1Registration filed0001193125-20-010195
2019-05-10
Health Sciences Acquisitions Corp
IPOFinal prospectusCIK 1764013
 424B4Final prospectus0001615774-19-007495
2019-05-09
Health Sciences Acquisitions Corp
IPOFinal prospectusCIK 1764013
 EFFECTDeclared effective9999999995-19-001071
2019-05-03
Health Sciences Acquisitions Corp
IPOFinal prospectusCIK 1764013
 S-1/AAmendment0001615774-19-007057
2019-04-29
Health Sciences Acquisitions Corp
IPOFinal prospectusCIK 1764013
 S-1/AAmendment0001615774-19-006497
2019-04-16
Health Sciences Acquisitions Corp
IPOFinal prospectusCIK 1764013
 S-1Registration filed0001615774-19-005792
2019-01-23
Health Sciences Acquisitions Corp
CIK 1764013
 DRSDraft made public0001615774-19-000807